{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,23]],"date-time":"2026-09-23T14:48:27Z","timestamp":1790174907256,"version":"4.1.0"},"reference-count":57,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2017,10,1]],"date-time":"2017-10-01T00:00:00Z","timestamp":1506816000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2017,10,1]],"date-time":"2017-10-01T00:00:00Z","timestamp":1506816000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2017,10,1]],"date-time":"2017-10-01T00:00:00Z","timestamp":1506816000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2017,10,1]],"date-time":"2017-10-01T00:00:00Z","timestamp":1506816000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2017,10,1]],"date-time":"2017-10-01T00:00:00Z","timestamp":1506816000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2017,10,1]],"date-time":"2017-10-01T00:00:00Z","timestamp":1506816000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2017,10,1]],"date-time":"2017-10-01T00:00:00Z","timestamp":1506816000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"name":"Soci\u00e9t\u00e9 Fran\u00e7aise de Rhumatologie","award":["2818"],"award-info":[{"award-number":["2818"]}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Bone"],"published-print":{"date-parts":[[2017,10]]},"DOI":"10.1016\/j.bone.2017.07.002","type":"journal-article","created":{"date-parts":[[2017,7,3]],"date-time":"2017-07-03T02:30:16Z","timestamp":1499049016000},"page":"150-158","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":34,"special_numbering":"C","title":["Involvement of sphingosine kinase\/sphingosine 1-phosphate metabolic pathway in spondyloarthritis"],"prefix":"10.1016","volume":"103","author":[{"given":"Carole","family":"Bougault","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alaeddine","family":"El Jamal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anne","family":"Briolay","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Saida","family":"Mebarek","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1519-6902","authenticated-orcid":false,"given":"Marie-Astrid","family":"Boutet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas","family":"Garraud","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Benoit","family":"Le Goff","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fr\u00e9deric","family":"Blanchard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Magne","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5227-8811","authenticated-orcid":false,"given":"Leyre","family":"Brizuela","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"6","key":"10.1016\/j.bone.2017.07.002_bb0005","doi-asserted-by":"crossref","first-page":"905","DOI":"10.1002\/acr.21621","article-title":"Prevalence of axial spondyloarthritis in the United States: estimates from a cross-sectional survey","volume":"64","author":"Reveille","year":"2012","journal-title":"Arthritis Care Res."},{"issue":"4","key":"10.1016\/j.bone.2017.07.002_bb0010","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1136\/annrheumdis-2013-204436","article-title":"Prevalence of spondyloarthritis in reference to HLA-B27 in the French population: results of the GAZEL cohort","volume":"74","author":"Costantino","year":"2015","journal-title":"Ann. Rheum. Dis."},{"issue":"10","key":"10.1016\/j.bone.2017.07.002_bb0015","doi-asserted-by":"crossref","first-page":"562","DOI":"10.1038\/nrrheum.2015.128","article-title":"The IL-23-IL-17 axis in inflammatory arthritis","volume":"11","author":"Lubberts","year":"2015","journal-title":"Nat. Rev. Rheumatol."},{"issue":"5","key":"10.1016\/j.bone.2017.07.002_bb0020","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1517\/14712598.2016.1167183","article-title":"Secukinumab (AIN457) in the treatment of ankylosing spondylitis","volume":"16","author":"Braun","year":"2016","journal-title":"Expert. Opin. Biol. Ther."},{"key":"10.1016\/j.bone.2017.07.002_bb0025","article-title":"Secukinumab efficacy in anti-TNF-naive and anti-TNF-experienced subjects with active ankylosing spondylitis: results from the MEASURE 2 Study","author":"Sieper","year":"2016","journal-title":"Ann. Rheum. Dis."},{"issue":"12","key":"10.1016\/j.bone.2017.07.002_bb0030","doi-asserted-by":"crossref","first-page":"3789","DOI":"10.1002\/art.30627","volume":"63","author":"Pedersen","year":"2011","journal-title":"Arthritis Rheum."},{"issue":"4","key":"10.1016\/j.bone.2017.07.002_bb0035","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1210\/er.2007-0025","article-title":"Sphingolipids, insulin resistance, and metabolic disease: new insights from in vivo manipulation of sphingolipid metabolism","volume":"29","author":"Holland","year":"2008","journal-title":"Endocr. Rev."},{"issue":"1","key":"10.1016\/j.bone.2017.07.002_bb0040","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1016\/j.tcb.2011.09.003","article-title":"Sphingosine-1-phosphate signaling and its role in disease","volume":"22","author":"Maceyka","year":"2012","journal-title":"Trends Cell Biol."},{"key":"10.1016\/j.bone.2017.07.002_bb0045","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/978-1-4419-6741-1_1","article-title":"An overview of sphingolipid metabolism: from synthesis to breakdown","volume":"688","author":"Gault","year":"2010","journal-title":"Adv. Exp. Med. Biol."},{"issue":"4","key":"10.1016\/j.bone.2017.07.002_bb0050","doi-asserted-by":"crossref","first-page":"1416","DOI":"10.1172\/JCI60746","article-title":"The sphingosine-1-phosphate transporter Spns2 expressed on endothelial cells regulates lymphocyte trafficking in mice","volume":"122","author":"Fukuhara","year":"2012","journal-title":"J. Clin. Invest."},{"issue":"3","key":"10.1016\/j.bone.2017.07.002_bb0055","doi-asserted-by":"crossref","first-page":"1001","DOI":"10.1096\/fj.12-219618","article-title":"Spns2, a transporter of phosphorylated sphingoid bases, regulates their blood and lymph levels, and the lymphatic network","volume":"27","author":"Nagahashi","year":"2013","journal-title":"FASEB J."},{"issue":"5","key":"10.1016\/j.bone.2017.07.002_bb0060","doi-asserted-by":"crossref","first-page":"766","DOI":"10.1016\/j.bbalip.2013.08.014","article-title":"Sphingosine 1-phosphate is a key metabolite linking sphingolipids to glycerophospholipids","volume":"1841","author":"Kihara","year":"2014","journal-title":"Biochim. Biophys. Acta"},{"issue":"2","key":"10.1016\/j.bone.2017.07.002_bb0065","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/j.tibs.2010.08.001","article-title":"Regulation of sphingosine kinase and sphingolipid signaling","volume":"36","author":"Pitson","year":"2011","journal-title":"Trends Biochem. Sci."},{"issue":"6585","key":"10.1016\/j.bone.2017.07.002_bb0070","doi-asserted-by":"crossref","first-page":"800","DOI":"10.1038\/381800a0","article-title":"Suppression of ceramide-mediated programmed cell death by sphingosine-1-phosphate","volume":"381","author":"Cuvillier","year":"1996","journal-title":"Nature"},{"issue":"5","key":"10.1016\/j.bone.2017.07.002_bb0075","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1038\/nrm1103","article-title":"Sphingosine-1-phosphate: an enigmatic signalling lipid","volume":"4","author":"Spiegel","year":"2003","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"10.1016\/j.bone.2017.07.002_bb0080","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1016\/j.plipres.2015.06.002","article-title":"Understanding the local actions of lipids in bone physiology","volume":"59","author":"During","year":"2015","journal-title":"Prog. Lipid Res."},{"issue":"5","key":"10.1016\/j.bone.2017.07.002_bb0085","doi-asserted-by":"crossref","first-page":"959","DOI":"10.1007\/s00018-014-1778-x","article-title":"Sphingolipid metabolism and its role in the skeletal tissues","volume":"72","author":"Khavandgar","year":"2015","journal-title":"Cell. Mol. Life Sci."},{"issue":"24","key":"10.1016\/j.bone.2017.07.002_bb0090","doi-asserted-by":"crossref","first-page":"5840","DOI":"10.1038\/sj.emboj.7601430","article-title":"Sphingosine 1-phosphate as a regulator of osteoclast differentiation and osteoclast-osteoblast coupling","volume":"25","author":"Ryu","year":"2006","journal-title":"EMBO J."},{"issue":"52","key":"10.1016\/j.bone.2017.07.002_bb0095","doi-asserted-by":"crossref","first-page":"20764","DOI":"10.1073\/pnas.0805133106","article-title":"Regulation of bone formation by osteoclasts involves Wnt\/BMP signaling and the chemokine sphingosine-1-phosphate","volume":"105","author":"Pederson","year":"2008","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.bone.2017.07.002_bb0100","doi-asserted-by":"crossref","first-page":"5215","DOI":"10.1038\/ncomms6215","article-title":"Calcitonin controls bone formation by inhibiting the release of sphingosine 1-phosphate from osteoclasts","volume":"5","author":"Keller","year":"2014","journal-title":"Nat. Commun."},{"issue":"1","key":"10.1016\/j.bone.2017.07.002_bb0105","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1016\/j.bbalip.2012.06.002","article-title":"Sphingosine-1-phosphate signaling controlling osteoclasts and bone homeostasis","volume":"1831","author":"Ishii","year":"2013","journal-title":"Biochim. Biophys. Acta"},{"issue":"6","key":"10.1016\/j.bone.2017.07.002_bb0110","doi-asserted-by":"crossref","first-page":"542","DOI":"10.1007\/s00223-003-0155-9","article-title":"Osteoblastic cells express phospholipid receptors and phosphatases and proliferate in response to sphingosine-1-phosphate","volume":"74","author":"Grey","year":"2004","journal-title":"Calcif. Tissue Int."},{"issue":"3","key":"10.1016\/j.bone.2017.07.002_bb0115","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1016\/S0952-3278(02)00277-6","article-title":"Effects of sphingosine-1-phosphate and lysophosphatidic acid on human osteoblastic cells","volume":"68","author":"Dziak","year":"2003","journal-title":"Prostaglandins Leukot. Essent. Fat. Acids"},{"issue":"1","key":"10.1016\/j.bone.2017.07.002_bb0120","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1016\/j.bbrc.2009.11.118","article-title":"Sphingosine kinase-1 mediates androgen-induced osteoblast cell growth","volume":"391","author":"Martin","year":"2010","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.bone.2017.07.002_bb0125","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.bone.2016.09.003","article-title":"Sphingosine-1-phosphate\/S1PR2-mediated signaling triggers Smad1\/5\/8 phosphorylation and thereby induces Runx2 expression in osteoblasts","volume":"93","author":"Higashi","year":"2016","journal-title":"Bone"},{"issue":"1","key":"10.1016\/j.bone.2017.07.002_bb0130","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1016\/j.bbrc.2012.05.130","article-title":"Sphingosine 1-phosphate receptor activation enhances BMP-2-induced osteoblast differentiation","volume":"423","author":"Sato","year":"2012","journal-title":"Biochem. Biophys. Res. Commun."},{"issue":"2","key":"10.1016\/j.bone.2017.07.002_bb0135","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1016\/j.bone.2013.04.008","article-title":"Sphingosine-1-phosphate promotes the nuclear translocation of \u03b2-catenin and thereby induces osteoprotegerin gene expression in osteoblast-like cell lines","volume":"55","author":"Matsuzaki","year":"2013","journal-title":"Bone"},{"issue":"10","key":"10.1016\/j.bone.2017.07.002_bb0140","doi-asserted-by":"crossref","first-page":"1129","DOI":"10.1002\/cbin.10652","article-title":"Sphingosine-1-phosphate-enhanced Wnt5a promotes osteogenic differentiation in C3H10T1\/2 cells","volume":"40","author":"Hashimoto","year":"2016","journal-title":"Cell Biol. Int."},{"issue":"1","key":"10.1016\/j.bone.2017.07.002_bb0145","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/j.bbrc.2006.04.042","article-title":"Sphingosine-1-phosphate stimulates rat primary chondrocyte proliferation","volume":"345","author":"Kim","year":"2006","journal-title":"Biochem. Biophys. Res. Commun."},{"issue":"8","key":"10.1016\/j.bone.2017.07.002_bb0150","doi-asserted-by":"crossref","first-page":"2113","DOI":"10.1002\/art.37989","article-title":"Sphingosine 1-phosphate counteracts the effects of interleukin-1\u03b2 in human chondrocytes","volume":"65","author":"Stradner","year":"2013","journal-title":"Arthritis Rheum."},{"issue":"8","key":"10.1016\/j.bone.2017.07.002_bb0155","doi-asserted-by":"crossref","first-page":"5157","DOI":"10.1007\/s11033-014-3382-4","article-title":"Knockdown of sphingosine kinase 1 inhibits the migration and invasion of human rheumatoid arthritis fibroblast-like synoviocytes by down-regulating the PI3K\/AKT activation and MMP-2\/9 production in vitro","volume":"41","author":"Yuan","year":"2014","journal-title":"Mol. Biol. Rep."},{"issue":"18","key":"10.1016\/j.bone.2017.07.002_bb0160","first-page":"5962","article-title":"Discovery and evaluation of inhibitors of human sphingosine kinase","volume":"63","author":"French","year":"2003","journal-title":"Cancer Res."},{"issue":"1","key":"10.1016\/j.bone.2017.07.002_bb0165","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1042\/BJ20111929","article-title":"Modulation of cellular S1P levels with a novel, potent and specific inhibitor of sphingosine kinase-1","volume":"444","author":"Schnute","year":"2012","journal-title":"Biochem. J."},{"issue":"2","key":"10.1016\/j.bone.2017.07.002_bb0170","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0056471","article-title":"Biological characterization of 3-(2-amino-ethyl)-5-[3-(4-butoxyl-phenyl)-propylidene]-thiazolidine-2,4-dione (K145) as a selective sphingosine kinase-2 inhibitor and anticancer agent","volume":"8","author":"Liu","year":"2013","journal-title":"PLoS One"},{"issue":"1","key":"10.1016\/j.bone.2017.07.002_bb0175","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1136\/ard.2010.133645","article-title":"The Assessment of SpondyloArthritis International Society classification criteria for peripheral spondyloarthritis and for spondyloarthritis in general","volume":"70","author":"Rudwaleit","year":"2011","journal-title":"Ann. Rheum. Dis."},{"issue":"9","key":"10.1016\/j.bone.2017.07.002_bb0180","doi-asserted-by":"crossref","first-page":"1580","DOI":"10.1136\/ard.2010.138461","article-title":"2010 rheumatoid arthritis classification criteria: an American College of Rheumatology\/European League Against Rheumatism collaborative initiative","volume":"69","author":"Aletaha","year":"2010","journal-title":"Ann. Rheum. Dis."},{"issue":"4","key":"10.1016\/j.bone.2017.07.002_bb0185","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1016\/j.joca.2008.09.007","article-title":"Mechanical loading highly increases IL-6 production and decreases OPG expression by osteoblasts","volume":"17","author":"Sanchez","year":"2009","journal-title":"Osteoarthr. Cartil."},{"issue":"8","key":"10.1016\/j.bone.2017.07.002_bb0190","doi-asserted-by":"crossref","first-page":"1253","DOI":"10.1038\/nprot.2008.95","article-title":"Primary culture and phenotyping of murine chondrocytes","volume":"3","author":"Gosset","year":"2008","journal-title":"Nat. Protoc."},{"key":"10.1016\/j.bone.2017.07.002_bb0195","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1186\/1749-799X-4-9","article-title":"Passage and concentration-dependent effects of indomethacin on tendon derived cells","volume":"4","author":"Mallick","year":"2009","journal-title":"J. Orthop. Surg. Res."},{"issue":"10","key":"10.1016\/j.bone.2017.07.002_bb0200","doi-asserted-by":"crossref","first-page":"3882","DOI":"10.1096\/fj.10-160838","article-title":"The sphingosine kinase-1 survival pathway is a molecular target for the tumor-suppressive tea and wine polyphenols in prostate cancer","volume":"24","author":"Brizuela","year":"2010","journal-title":"FASEB J."},{"issue":"9","key":"10.1016\/j.bone.2017.07.002_bb0205","doi-asserted-by":"crossref","first-page":"1841","DOI":"10.1158\/1535-7163.MCT-12-0227","article-title":"First evidence of sphingosine 1-phosphate lyase protein expression and activity downregulation in human neoplasm: implication for resistance to therapeutics in prostate cancer","volume":"11","author":"Brizuela","year":"2012","journal-title":"Mol. Cancer Ther."},{"key":"10.1016\/j.bone.2017.07.002_bb0210","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1007\/978-1-61779-800-9_2","article-title":"Isoform-selective assays for sphingosine kinase activity","volume":"874","author":"Pitman","year":"2012","journal-title":"Methods Mol. Biol."},{"key":"10.1016\/j.bone.2017.07.002_bb0215","doi-asserted-by":"crossref","DOI":"10.1016\/j.trsl.2015.06.010","article-title":"Wnt5a is expressed in spondyloarthritis and exerts opposite effects on enthesis and bone in murine organ and cell cultures","author":"Bougault","year":"2015","journal-title":"Transl. Res."},{"issue":"5","key":"10.1016\/j.bone.2017.07.002_bb0220","doi-asserted-by":"crossref","first-page":"969","DOI":"10.1093\/oxfordjournals.jbchem.a021681","article-title":"Sphingosine 1-phosphate, a bioactive sphingolipid abundantly stored in platelets, is a normal constituent of human plasma and serum","volume":"121","author":"Yatomi","year":"1997","journal-title":"J. Biochem."},{"issue":"11","key":"10.1016\/j.bone.2017.07.002_bb0225","doi-asserted-by":"crossref","first-page":"321","DOI":"10.4331\/wjbc.v1.i11.321","article-title":"Role of sphingosine kinase and sphingosine-1-phosphate in inflammatory arthritis","volume":"1","author":"Lai","year":"2010","journal-title":"World J. Biol. Chem."},{"issue":"11","key":"10.1016\/j.bone.2017.07.002_bb0230","doi-asserted-by":"crossref","first-page":"8010","DOI":"10.4049\/jimmunol.181.11.8010","article-title":"Anti-inflammatory effects of sphingosine kinase modulation in inflammatory arthritis","volume":"181","author":"Lai","year":"2008","journal-title":"J. Immunol."},{"issue":"10","key":"10.1016\/j.bone.2017.07.002_bb0235","doi-asserted-by":"crossref","first-page":"1203","DOI":"10.1016\/j.cellsig.2004.12.005","article-title":"Basal and induced sphingosine kinase 1 activity in A549 carcinoma cells: function in cell survival and IL-1beta and TNF-alpha induced production of inflammatory mediators","volume":"17","author":"Billich","year":"2005","journal-title":"Cell. Signal."},{"issue":"7301","key":"10.1016\/j.bone.2017.07.002_bb0240","doi-asserted-by":"crossref","first-page":"1084","DOI":"10.1038\/nature09128","article-title":"Sphingosine-1-phosphate is a missing cofactor for the E3 ubiquitin ligase TRAF2","volume":"465","author":"Alvarez","year":"2010","journal-title":"Nature"},{"issue":"6","key":"10.1016\/j.bone.2017.07.002_bb0245","doi-asserted-by":"crossref","first-page":"852","DOI":"10.1016\/j.joca.2014.04.008","article-title":"The role of ANK interactions with MYBBP1a and SPHK1 in catabolic events of articular chondrocytes","volume":"22","author":"Minashima","year":"2014","journal-title":"Osteoarthr. Cartil."},{"issue":"11","key":"10.1016\/j.bone.2017.07.002_bb0250","doi-asserted-by":"crossref","first-page":"1411","DOI":"10.1096\/fj.02-1038com","article-title":"The sphingosine kinase 1\/sphingosine-1-phosphate pathway mediates COX-2 induction and PGE2 production in response to TNF-alpha","volume":"17","author":"Pettus","year":"2003","journal-title":"FASEB J."},{"issue":"3","key":"10.1016\/j.bone.2017.07.002_bb0255","doi-asserted-by":"crossref","first-page":"742","DOI":"10.1002\/art.21668","article-title":"Sphingosine 1-phosphate\/sphingosine 1-phosphate receptor 1 signaling in rheumatoid synovium: regulation of synovial proliferation and inflammatory gene expression","volume":"54","author":"Kitano","year":"2006","journal-title":"Arthritis Rheum."},{"issue":"11","key":"10.1016\/j.bone.2017.07.002_bb0260","doi-asserted-by":"crossref","first-page":"2323","DOI":"10.1194\/jlr.M800143-JLR200","article-title":"Specific and overlapping sphingosine-1-phosphate receptor functions in human synoviocytes: impact of TNF-alpha","volume":"49","author":"Zhao","year":"2008","journal-title":"J. Lipid Res."},{"issue":"1","key":"10.1016\/j.bone.2017.07.002_bb0265","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1016\/j.joca.2012.11.012","article-title":"Osteoarthritis as an inflammatory disease (osteoarthritis is not osteoarthrosis!)","volume":"21","author":"Berenbaum","year":"2013","journal-title":"Osteoarthr. Cartil."},{"issue":"3\u20134","key":"10.1016\/j.bone.2017.07.002_bb0270","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1159\/000323911","article-title":"Experimental osteoarthritis in rats is attenuated by ABC294640, a selective inhibitor of sphingosine kinase-2","volume":"87","author":"Fitzpatrick","year":"2011","journal-title":"Pharmacology"},{"issue":"3","key":"10.1016\/j.bone.2017.07.002_bb0275","doi-asserted-by":"crossref","first-page":"2097","DOI":"10.4049\/jimmunol.0804376","article-title":"Distinct roles of sphingosine kinase 1 and 2 in murine collagen-induced arthritis","volume":"183","author":"Lai","year":"2009","journal-title":"J. Immunol."},{"issue":"7","key":"10.1016\/j.bone.2017.07.002_bb0280","doi-asserted-by":"crossref","first-page":"1181","DOI":"10.1016\/j.molonc.2014.04.001","article-title":"Osteoblast-derived sphingosine 1-phosphate to induce proliferation and confer resistance to therapeutics to bone metastasis-derived prostate cancer cells","volume":"8","author":"Brizuela","year":"2014","journal-title":"Mol. Oncol."},{"key":"10.1016\/j.bone.2017.07.002_bb0285","doi-asserted-by":"crossref","DOI":"10.1096\/fj.15-274936","article-title":"Spinster 2, a sphingosine-1-phosphate transporter, plays a critical role in inflammatory and autoimmune diseases","author":"Donoviel","year":"2015","journal-title":"FASEB J."}],"container-title":["Bone"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S8756328217302284?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S8756328217302284?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,11]],"date-time":"2025-09-11T17:42:18Z","timestamp":1757612538000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S8756328217302284"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,10]]},"references-count":57,"alternative-id":["S8756328217302284"],"URL":"https:\/\/doi.org\/10.1016\/j.bone.2017.07.002","relation":{},"ISSN":["8756-3282"],"issn-type":[{"value":"8756-3282","type":"print"}],"subject":[],"published":{"date-parts":[[2017,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Involvement of sphingosine kinase\/sphingosine 1-phosphate metabolic pathway in spondyloarthritis","name":"articletitle","label":"Article Title"},{"value":"Bone","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bone.2017.07.002","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}